Privacy Policy Contact OAR Sign In

News & Advocacy

Displaying results 41-60 (of 137)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7  > 

Ohio Association of Rheumatology Offers Perspective on the Use and Availability of Hydroxychloroquine and Chloroquine

posted: April 21, 2020
Hydroxychloroquine is a FDA-approved drug prescribed for the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and many more in addition to serving as an... Read More

Cancelled: OAR 2020 Advocacy Day

posted: April 16, 2020
Due to the ongoing uncertainty regarding the COVID-19 pandemic, OAR is postponing the 2020 Advocacy Day which was to be held on May 21, to a future date yet to be determined. We will be monitoring... Read More

Management of COVID-19 in Ohio

posted: March 23, 2020
Telemedicine is at the top of Ohio decisionmakers’ list right now in response to the pandemic.The State Medical Board of Ohio (SMBO, Medical Board) met on Wednesday, March 18, 2020 and voted... Read More

Congress Moves Swiftly to Address COVID-19 Pandemic

posted: March 23, 2020
ongress and the Administration have been working around the clock as policymakers roll out a three phase economic relief package to address the pandemic and those hit hardest by COVID-19.Phase 1 of... Read More

Non-Medical Switching Reform Legislation Given House Health Committee Consideration

posted: March 23, 2020
Ohio House Bill 418 was Introduced in the Ohio Legislature by Joint Sponsors Representatives Carruthers (R-51) and Clites (D-75) in November. The bill protects patients by prohibiting medication... Read More

Telehealth Expansion and Medicare

posted: March 23, 2020
Regulations on Telehealth have literally lessened overnight, and the medical community is now faced with implementing the use of telemedicine in their practices without delay, and many of them for... Read More

Help Patients Impacted by Non-Medical Switching – Share Your Story TODAY!

posted: March 23, 2020
OAR is looking to hear from providers and patients who have been impacted by non-medical switching practices to share their experiences. Your testimony will bring greater awareness to the negative... Read More

Ohio Providers to Participate in Next Advocacy Day on May 21, 2020

posted: March 23, 2020
OAR is carefully monitoring the COVID-19 pandemic and will update the OAR website registration page to reflect any changes. Please register and save the date on your calendar to attend this... Read More

New Legislation Addresses Unfair and Deceptive Pharmacy Benefit Manager (PBM) and Insurer Practices

posted: March 20, 2020
In order to reduce drug costs and improve patient access to treatment, OAR believes increased transparency and appropriate oversight of how PBMs operate in Ohio should be of high priority for... Read More

Ohio Department of Medicaid (ODM) Rolls Out New Unified Preferred Drug List

posted: March 20, 2020
The ODM began implementation of their Unified Preferred Drug List (UPDL) on January 1, 2020. According to the ODM, the UPDL was developed to reduce confusion, hassles, and potential delays for... Read More

CSRO Launches New Legislative Map Tool

posted: March 20, 2020
Providers of rheumatology across the country are now able to access information on enacted laws and pending legislation that affects their practices through CSRO’s new map tool. View... Read More

OAR Takes the Lead on Reforming Non-Medical Switching

posted: December 2, 2019
OAR is pleased to announce that House Bill 418 was Introduced in the Ohio Legislature by Joint Sponsors Representatives Carruthers (R) and Clites (D) in November. OAR looks forward to leading the... Read More

New Legislation Filed to Increase PBM Transparency

posted: December 2, 2019
The current rebate system allows for pharmacy benefit managers (PBMs) to reap profits on the backs of health plans and patients. In order to reduce drug costs and improve patient access to... Read More

OAR to Hold Next Advocacy with the Arthritis Foundation

posted: December 2, 2019
The 7th Annual OAR Joint Advocacy Day with the Arthritis Foundation will be held in April 2020. Advocates will gather in downtown Columbus for breakfast and a legislative briefing prior to... Read More

OAR Submits Letter to the Department of Medicaid on Formulary Driven Switches

posted: December 2, 2019
Coverage changes have occurred under Paramount plans due to the way Paramount is now managing their pharmacy benefits. Magellan Rx Management, a pharmacy benefit manager (PBM), is under contract... Read More

Report Released on PBM Spread Pricing and the New Pass-Through Model

posted: December 2, 2019
Following a report released in September, Medicaid Director Maureen Corcoran proclaimed the state was now getting a better deal on prescription drugs due to the success of the “pass-through... Read More

Unified Preferred Drug List for All Ohio Medicaid Beneficiaries

posted: December 2, 2019
Beginning January 1, 2020, the Ohio Department of Medicaid (ODM) and Medicaid Managed Care Plans (MCPs) will begin using a Unified Preferred Drug List (UPDL) which will establish a single PBM to... Read More

Ohio Getting a Better Deal from PBMs, but Many Questions Remain

posted: October 7, 2019
More information can be found on Read the Full Article

Ohio’s Pharmacy Benefit Managers back in Spotlight of Medicaid Oversight Panel

posted: September 23, 2019
Find out more on the Columbus Dispatch. Read More

OAR President Dr. Stephanie Ott Presents Advocacy Update at Annual Conference

posted: September 4, 2019
OAR members and attendees at the annual conference on August 24, 2019 who attended Dr. Ott’s Advocacy Update session heard a summary of all the activities OAR has conducted over the course of... Read More

Displaying results 41-60 (of 137)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7  >